Survival After Coronary Artery Bypass Grafting in Patients With Preoperative Heart Failure and Preserved vs Reduced Ejection Fraction

被引:40
作者
Dalen, Magnus [1 ,2 ]
Lund, Lars H. [3 ,4 ]
Ivert, Torbjorn [1 ,2 ]
Holzmann, Martin J. [4 ,5 ]
Sartipy, Ulrik [1 ,2 ]
机构
[1] Karolinska Univ Hosp, Dept Cardiothorac Surg & Anesthesiol, SE-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden
[4] Karolinska Inst, Dept Med, Stockholm, Sweden
[5] Karolinska Univ Hosp, Dept Emergency Med, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
LONG-TERM SURVIVAL; CARDIAC-SURGERY; OUTCOMES; RISK; DYSFUNCTION; REGISTRY; DISEASE; ASSOCIATION; PREVALENCE; VALIDATION;
D O I
10.1001/jamacardio.2016.1465
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Data on the prognostic consequence of heart failure (HF) with preserved ejection fraction in patients undergoing coronary artery bypass grafting (CABG) are limited and inconclusive. OBJECTIVE To investigate the survival after CABG in patients with preoperative HF and preserved ejection fraction (pEF) vs reduced ejection fraction (rEF). DESIGN, SETTING, AND PARTICIPANTS Swedish nationwide population-based cohort study that included all patients who underwent primary isolated CABG between January 1, 2001, and December 31, 2013, from the SwedishWeb-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) register, with follow-up for all-cause mortality in March 2014. Information regarding baseline characteristics, all-cause mortality, and readmissions for HF was obtained from national health data registers. Preserved EF was defined as at least 50%. MAIN OUTCOMES AND MEASURES The primary outcomewas all-cause mortality. A secondary outcome measure was a combination of all-cause mortality and readmission for HF. RESULTS The study included 41 906 patients, 37 234 without known HF (27 165 with pEF and 10 069 with rEF) and 4672 with HF (1216 with pEF and 3456 with rEF). Their mean (SD) age was 67.4 (9.3) years, and 21.0% were female. During a mean (SD) follow-up time of 6.0 (3.3) years, 19.0%(7943 of 41 906) of patients died, including 13.2%(3574 of 27 165) with no HF and pEF, 24.6%(2476 of 10 069) with no HF and rEF, 33.9% (412 of 1216) with HFpEF, and 42.9%(1481 of 3456) with HFrEF. The multivariable-adjusted hazard ratios for death were 1.47 (95% CI, 1.40-1.56), 1.62 (95% CI, 1.46-1.80), and 2.29 (95% CI, 2.14-2.44) in patients with no HF and rEF, patients with HFpEF, and patients with HFrEF compared with patients with no HF and pEF. The findings were similar for the combined outcome of all-cause mortality and readmission for HF. The multivariable-adjusted hazard ratios for death within 30 days of surgery were 2.25 (95% CI, 1.86-2.73), 1.83 (95% CI, 1.26-2.66), and 2.52 (95% CI, 1.99-3.19) in patients with no HF and rEF, patients with HFpEF, and patients with HFrEF. CONCLUSIONS AND RELEVANCE A history of HF was an important risk factor for poor short-term and long-term outcomes after CABG regardless of preoperative EF. Reduced EF more than doubled the risk of early death after CABG.
引用
收藏
页码:530 / 538
页数:9
相关论文
共 50 条
  • [41] Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction
    Oraii, Alireza
    McIntyre, William F.
    Parkash, Ratika
    Kowalik, Krzysztof
    Razeghi, Ghazal
    Benz, Alexander P.
    Belley-Cote, Emilie P.
    Conen, David
    Connolly, Stuart J.
    Tang, Anthony S. L.
    Healey, Jeff S.
    Wong, Jorge A.
    [J]. JAMA CARDIOLOGY, 2024, 9 (06) : 545 - 555
  • [42] Comparison of Beta-Blocker Effectiveness in Heart Failure Patients With Preserved Ejection Fraction Versus Those With Reduced Ejection Fraction
    El-Refai, Mostafa
    Peterson, Edward L.
    Wells, Karen
    Swadia, Tanmay
    Sabbah, Hani N.
    Spertus, John A.
    Williams, L. Keoki
    Lanfear, David E.
    [J]. JOURNAL OF CARDIAC FAILURE, 2013, 19 (02) : 73 - 79
  • [43] Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF)
    Sobue, Yoshihiro
    Watanabe, Eiichi
    Lip, Gregory Y. H.
    Koshikawa, Masayuki
    Ichikawa, Tomohide
    Kawai, Mayumi
    Harada, Masahide
    Inamasu, Joji
    Ozaki, Yukio
    [J]. HEART AND VESSELS, 2018, 33 (04) : 403 - 412
  • [44] Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction
    Tromp, Jasper
    Lim, Shir Lynn
    Tay, Wan Ting
    Teng, Tiew-Hwa Katherine
    Chandramouli, Chanchal
    Ouwerkerk, Wouter
    Wander, Gupreet S.
    Sawhney, Jitendra P. S.
    Yap, Jonathan
    MacDonald, Michael R.
    Ling, Lieng Hsi
    Sattar, Naveed
    McMurray, John J. V.
    Richards, A. Mark
    Anand, Inder
    Lam, Carolyn S. P.
    [J]. DIABETES CARE, 2019, 42 (09) : 1792 - 1799
  • [45] Diagnosing Heart Failure with Preserved Ejection Fraction in Obese Patients
    Basha, Marino
    Stavropoulou, Evdoxia
    Nikolaidou, Anastasia
    Dividis, Georgios
    Peteinidou, Emmanouela
    Tsioufis, Panagiotis
    Kamperidis, Nikolaos
    Dimitriadis, Kyriakos
    Karamitsos, Theodoros
    Giannakoulas, George
    Tsioufis, Konstantinos
    Ziakas, Antonios
    Kamperidis, Vasileios
    [J]. JOURNAL OF CLINICAL MEDICINE, 2025, 14 (06)
  • [46] Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction
    Rush, Christopher J.
    Berry, Colin
    Oldroyd, Keith G.
    Rocchiccioli, J. Paul
    Lindsay, M. Mitchell
    Touyz, Rhian M.
    Murphy, Clare L.
    Ford, Thomas J.
    Sidik, Novalia
    McEntegart, Margaret B.
    Lang, Ninian N.
    Jhund, Pardeep S.
    Campbell, Ross T.
    McMurray, John J. V.
    Petrie, Mark C.
    [J]. JAMA CARDIOLOGY, 2021, 6 (10) : 1130 - 1143
  • [47] Unraveling the Predictors for Delirium and ICU Stay Duration in Patients with Heart Failure and Reduced Ejection Fraction (HFrEF) Undergoing Coronary Artery Bypass Grafting-A Multicentric Analysis
    Rustenbach, Christian Jorg
    Reichert, Stefan
    Berger, Rafal
    Schano, Julia
    Nemeth, Attila
    Haeberle, Helene
    Charotte, Christophe
    Caldonazo, Tulio
    Saqer, Ibrahim
    Saha, Shekhar
    Schnackenburg, Philipp
    Djordjevic, Ilija
    Krasivskyi, Ihor
    Wendt, Stefanie
    Serna-Higuita, Lina Maria
    Doenst, Torsten
    Hagl, Christian
    Wahlers, Thorsten
    Schlensak, Christian
    Boburg, Rodrigo Sandoval
    [J]. BIOMEDICINES, 2024, 12 (04)
  • [48] Mode of Death in Patients With Heart Failure and Reduced vs. Preserved Ejection Fraction - Report From the Registry of Hospitalized Heart Failure Patients
    Hamaguchi, Sanae
    Kinugawa, Shintaro
    Sobirin, Mochamad Ali
    Goto, Daisuke
    Tsuchihashi-Makaya, Miyuki
    Yamada, Satoshi
    Yokoshiki, Hisashi
    Tsutsui, Hiroyuki
    [J]. CIRCULATION JOURNAL, 2012, 76 (07) : 1662 - 1669
  • [49] Disproportionately low BNP levels in patients of acute heart failure with preserved vs. reduced ejection fraction
    Sakane, Kazushi
    Kanzaki, Yumiko
    Tsuda, Kosuke
    Maeda, Daichi
    Sohmiya, Koichi
    Hoshiga, Masaaki
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 327 : 105 - 110
  • [50] THE EFFECT OF LOW EJECTION FRACTION ON MORTALITY IN CORONARY ARTERY BYPASS GRAFTING (CABG) PATIENTS
    Ahmed, Haseeb
    Khan, Meenal Sikander
    Shakil, Rafat
    Jan, Azam
    Khan, Bahauddin
    Ul Islam, Mujahid
    Khan, Ahmad Deedar
    Aman, Zarkesha
    Khan, Waasay Hassan
    Shah, Noor Ali
    [J]. GOMAL JOURNAL OF MEDICAL SCIENCES, 2023, 21 (01): : 37 - 41